4,609
edits
m an update |
mNo edit summary |
||
Line 10: | Line 10: | ||
!NWA | !NWA | ||
!HMB+D3 | !HMB+D3 | ||
!Centrum Silver Men 50+ | |||
!LifeExtension Two Per Day | |||
!OD side effect | !OD side effect | ||
|- | |- | ||
Line 19: | Line 21: | ||
|1,350 mcg | |1,350 mcg | ||
| | | | ||
|1,050 mcg RE | |||
|1,500 mcg RAE | |||
|liver toxin | |liver toxin | ||
|- | |- | ||
Line 28: | Line 32: | ||
|20 mg | |20 mg | ||
| | | | ||
|6 mg | |||
|75 mg | |||
|neurotoxin | |neurotoxin | ||
|- | |- | ||
Line 37: | Line 43: | ||
|90 mcg | |90 mcg | ||
| | | | ||
|100 mcg | |||
|300 mcg | |||
|no known toxicity | |no known toxicity | ||
|- | |- | ||
Line 46: | Line 54: | ||
|203 mg | |203 mg | ||
| | | | ||
|120 mg | |||
|470 mg | |||
|diarrhea, stomach cramps | |diarrhea, stomach cramps | ||
|- | |- | ||
Line 55: | Line 65: | ||
|50 mcg | |50 mcg | ||
|50 mcg (2000 IU) | |50 mcg (2000 IU) | ||
|15 mcg | |||
|50 mcg | |||
|hypercalcemia | |hypercalcemia | ||
|- | |- | ||
Line 64: | Line 76: | ||
|15 mg | |15 mg | ||
| | | | ||
|40 mg | |||
|67 mg | |||
|bleeding, nausea | |bleeding, nausea | ||
|- | |- | ||
Line 73: | Line 87: | ||
|120 mcg | |120 mcg | ||
| | | | ||
|60 mcg | |||
|0 mcg | |||
|no known toxicity | |no known toxicity | ||
|- | |- | ||
Line 82: | Line 98: | ||
|20 mg | |20 mg | ||
| | | | ||
|1.5 mg | |||
|75 mg | |||
|allergic reactions, nausea | |allergic reactions, nausea | ||
|- | |- | ||
Line 91: | Line 109: | ||
|20 mg | |20 mg | ||
| | | | ||
|1.7 mg | |||
|50 mg | |||
|yellow urine, no toxicity | |yellow urine, no toxicity | ||
|- | |- | ||
Line 100: | Line 120: | ||
|40 mg | |40 mg | ||
| | | | ||
|20 mg | |||
|50 mg | |||
|flushing, liver damage | |flushing, liver damage | ||
|- | |- | ||
Line 109: | Line 131: | ||
|400 mcg DFE | |400 mcg DFE | ||
| | | | ||
|510 mcg DFE | |||
|680 mcg DFE | |||
|reduces vB12 causing neurotoxicity | |reduces vB12 causing neurotoxicity | ||
|- | |- | ||
Line 118: | Line 142: | ||
|240 mcg | |240 mcg | ||
| | | | ||
|300 mcg | |||
|0 mcg | |||
|masks B12 deficiency | |masks B12 deficiency | ||
|- | |- | ||
Line 127: | Line 153: | ||
|33 mcg | |33 mcg | ||
| | | | ||
|30 mcg | |||
|300 mcg | |||
|no known toxicity | |no known toxicity | ||
|- | |- | ||
Line 136: | Line 164: | ||
|20 mg | |20 mg | ||
| | | | ||
|10 mg | |||
|50 mg | |||
|diarrhea, heartburn | |diarrhea, heartburn | ||
|- | |- | ||
Line 145: | Line 175: | ||
|20 mg | |20 mg | ||
| | | | ||
|0 mg | |||
|0 mg | |||
|liver toxicity, low blood pressure | |liver toxicity, low blood pressure | ||
|- | |- | ||
Line 154: | Line 186: | ||
|130 mg (calcium carbonate, dicalcium phosphate) | |130 mg (calcium carbonate, dicalcium phosphate) | ||
|19 mg (from 140 mg calcium HMB monohydrate) | |19 mg (from 140 mg calcium HMB monohydrate) | ||
|210 mg | |||
|0 mg | |||
|kidney stones, constipation | |kidney stones, constipation | ||
|- | |- | ||
Line 163: | Line 197: | ||
|150 mcg | |150 mcg | ||
| | | | ||
|150 mcg | |||
|150 mcg | |||
|thyroid dysfunction | |thyroid dysfunction | ||
|- | |- | ||
Line 172: | Line 208: | ||
|55 mg | |55 mg | ||
| | | | ||
|75 mg | |||
|100 mg | |||
|diarrhea, low blood pressure | |diarrhea, low blood pressure | ||
|- | |- | ||
Line 179: | Line 217: | ||
|8 mg | |8 mg | ||
|Undefined (45 mg) | |Undefined (45 mg) | ||
|0 mg | |||
|0 mg | |||
|0 mg | |0 mg | ||
|0 mg | |0 mg | ||
Line 190: | Line 230: | ||
|22 mg | |22 mg | ||
| | | | ||
|15 mg | |||
|25 mg | |||
|nausea, copper deficiency | |nausea, copper deficiency | ||
|- | |- | ||
Line 199: | Line 241: | ||
|200 mcg | |200 mcg | ||
| | | | ||
|21 mcg | |||
|200 mcg | |||
|hair loss, nail brittleness | |hair loss, nail brittleness | ||
|- | |- | ||
Line 208: | Line 252: | ||
|1.8 mg | |1.8 mg | ||
| | | | ||
|500 mcg | |||
|0 mg | |||
|liver damage, nausea | |liver damage, nausea | ||
|- | |- | ||
Line 217: | Line 263: | ||
|5.8 mg | |5.8 mg | ||
| | | | ||
|4 mg | |||
|2 mg | |||
|neurological effects | |neurological effects | ||
|- | |- | ||
Line 226: | Line 274: | ||
|45 mcg | |45 mcg | ||
| | | | ||
|50 mcg | |||
|100 mcg | |||
|gout-like symptoms | |gout-like symptoms | ||
|- | |- | ||
Line 234: | Line 284: | ||
|Undefined | |Undefined | ||
|0 mcg | |0 mcg | ||
|0 mcg | |||
|10 mcg | |||
|0 mcg | |0 mcg | ||
|kidney damage | |kidney damage | ||
Line 244: | Line 296: | ||
|0 mg | |0 mg | ||
|0 mcg | |0 mcg | ||
|0 mg | |||
|0 mg | |||
|no known toxicity | |no known toxicity | ||
|- | |- | ||
Line 251: | Line 305: | ||
|1,500 mg | |1,500 mg | ||
|Undefined | |Undefined | ||
|0 mg | |||
|0 mg | |||
|0 mg | |0 mg | ||
|0 mg | |0 mg | ||
Line 261: | Line 317: | ||
|Undefined | |Undefined | ||
|0 mg | |0 mg | ||
|0 mg | |||
|80 mg | |||
|0 mg | |0 mg | ||
|heart arrhythmias | |heart arrhythmias | ||
Line 270: | Line 328: | ||
|Undefined | |Undefined | ||
|0 mg | |0 mg | ||
|0 mg | |||
|20 mg | |||
|0 mg | |0 mg | ||
|calcium imbalance | |calcium imbalance | ||
Line 279: | Line 339: | ||
|Undefined | |Undefined | ||
|0 mcg | |0 mcg | ||
|0 mcg | |||
|5 mcg | |||
|0 mcg | |0 mcg | ||
|allergic reactions | |allergic reactions | ||
Line 288: | Line 350: | ||
|Undefined | |Undefined | ||
|0 mg | |0 mg | ||
|0 mg | |||
|2 mg | |||
|0 mg | |0 mg | ||
|no known toxicity | |no known toxicity | ||
Line 298: | Line 362: | ||
|0 mcg | |0 mcg | ||
|0 mcg | |0 mcg | ||
|60 mcg | |||
|200 mcg | |||
|kidney, liver damage | |kidney, liver damage | ||
|- | |- | ||
Line 306: | Line 372: | ||
|Undefined | |Undefined | ||
|0 mg | |0 mg | ||
|0 mg | |||
|72 mg | |||
|0 mg | |0 mg | ||
|acid-base imbalance | |acid-base imbalance | ||
Line 316: | Line 384: | ||
|0 mg | |0 mg | ||
|0 mg | |0 mg | ||
|0 mg | |||
|3 mg | |||
|nausea, reproductive issues | |nausea, reproductive issues | ||
|- | |- | ||
Line 323: | Line 393: | ||
|15 mg | |15 mg | ||
|Undefined (100 mg) | |Undefined (100 mg) | ||
|0 mg | |||
|0 mg | |||
|0 mg | |0 mg | ||
|0 mg | |0 mg | ||
Line 332: | Line 404: | ||
|4 mg | |4 mg | ||
|7 mg | |7 mg | ||
|0 mg | |||
|0 mg | |||
|0 mg | |0 mg | ||
|0 mg | |0 mg | ||
|tooth mottling, bone issues | |tooth mottling, bone issues | ||
|- | |||
|Lutein | |||
|Not established | |||
|Not established | |||
|Not established | |||
|Not established | |||
|0 mcg | |||
|0 mcg | |||
|300 mcg | |||
|5,000 mcg | |||
|No known toxicity | |||
|- | |||
|Lycopene | |||
|Not established | |||
|30 mg (informal) | |||
|Not established | |||
|Not established | |||
|0 mcg | |||
|0 mcg | |||
|600 mcg | |||
|1,000 mcg | |||
|No known toxicity | |||
|- | |||
|Zeaxanthin | |||
|Not established | |||
|Not established | |||
|Not established | |||
|Not established | |||
|0 mcg | |||
|0 mcg | |||
|0 mcg | |||
|155 mcg | |||
|No known toxicity | |||
|} | |} |